PROTEGO BIOPHARMA, INC.

Profile

Company Names

PROTEGO BIOPHARMA, INC.
PROTEGO BIOPHARMA

Addresses

10945 VISTA SORRENTO PARKWAY, SUITE 150, SAN DIEGO, CA 92130

3210 MERRYFIELD ROW, JLABS, SAN DIEGO, CA 92121

Phone Numbers

(858) 355-9290
8585312187

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$84,989,544.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-10-17 
$32,942,190.00 
$130,442,180.00 
$97,499,990.00 
Equity 
2
2021-10-19 
$51,047,342.00 
$51,047,342.00 
$0.00 
Equity 
1
2019-12-06 
$1,000,012.00 
$1,000,012.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SAOUSSEN 
 
BEN HALIMA 
DIRECTOR
XII MEDICAL, INC.   |  PROTEGO BIOPHARMA, INC.
LAURA 
 
BRASS 
DIRECTOR
E-SCAPE BIO, INC.   |  ESCAPE BIO, INC.   |  RIBON THERAPEUTICS, INC.   |  IMMUNITAS THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA, INC.   |  HYKU BIOSCIENCES INC.
SHELLEY 
 
CHU 
DIRECTOR
KALIDEX PHARMACEUTICALS, INC.   |  ABINGWORTH BIOVENTURES VII LP   |  VENATORX PHARMACEUTICALS, INC.   |  IFM QUATTRO, INC.   |  IFM CINQUE, INC.   |  IFM CONTINUA, INC.   |  SCORPION THERAPEUTICS, INC.   |  ENLAZA THERAPEUTICS, INC.   |  ABATA THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA   |  TRIANA BIOMEDICINES, INC.   |  SEISMIC THERAPEUTIC, INC.   |  ANTARES THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA, INC.   |  ODYSSEY THERAPEUTICS, INC.
EDWARD 
 
HURWITZ 
DIRECTOR
CALISTOGA PHARMACEUTICALS INC   |  APPLIED GENETIC TECHNOLOGIES CORP   |  PROTEGO BIOPHARMA   |  RECODE THERAPEUTICS, INC.   |  DYNE THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA, INC.
XIN 
 
JIANG 
EXECUTIVE OFFICER
PROTEGO BIOPHARMA
JEFFERY 
 
KELLY 
DIRECTOR
PROTEOSTASIS THERAPEUTICS, INC.   |  YUMANITY HOLDINGS, LLC   |  PROTEGO BIOPHARMA, INC.
JEFFERY 
W 
KELLY 
PROMOTER
PROTEGO BIOPHARMA
JEFFREY 
 
KELLY 
DIRECTOR
DESIGNLINE CORP   |  PROTEGO BIOPHARMA   |  OCEANSOUND PARTNERS CO-INVEST II, LP - SERIES E   |  OCEANSOUND PARTNERS CO-INVEST II, LP - SERIES F   |  OCEANSOUND PARTNERS FUND II, LP   |  OCEANSOUND PARTNERS FUND II (A), LP   |  OSP CO-INVEST II, LP - MB SERIES
HELEN 
 
KIM 
DIRECTOR
TRINITY BIOSYSTEMS INC   |  NGM BIOPHARMACEUTICALS INC   |  NEOGENE THERAPEUTICS, INC.   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  RECODE THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA   |  PROTEGO BIOPHARMA, INC.
RICHARD 
 
LABAUDINIERE 
DIRECTOR, EXECUTIVE OFFICER
PROTEGO BIOPHARMA
TIM 
 
LOHOFF 
DIRECTOR
PROTEGO BIOPHARMA, INC.   |  SLATE MEDICINES, INC.
JANWILLEM 
 
NAESENS 
DIRECTOR
FRONTIER MEDICINES CORP   |  CYTEIR THERAPEUTICS, INC.   |  AMBAGON THERAPEUTICS INC.   |  PROTEGO BIOPHARMA, INC.
HANK 
MICHAEL 
PETRASSI 
EXECUTIVE OFFICER
PROTEGO BIOPHARMA, INC.
BRENT 
J. 
WARNER 
EXECUTIVE OFFICER, DIRECTOR
PROTEGO BIOPHARMA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-12-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-17 
2021-10-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-19 
2019-12-17
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2019-12-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#